Phase II trial of cancer vaccine MUC-1 [CVac] in patients with resectable pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2013
At a glance
- Drugs Cancer vaccine MUC-1 (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 24 Jun 2013 The trial protocol will be finalised and applications for regulatory and ethics committee approvals will be initiated in the coming months, according to a Prima Biomed media release.
- 25 Mar 2013 New trial record
- 19 Mar 2013 Prima BioMed announced a grant from the Saxony Development Bank to support phase II trials of CVac in three cancer indications, according to a media release. The company will finalise trial protocols and announce detailed plans in Q2 of 2013.